Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Abingdon Health PLC ( (GB:ABDX) ) is now available.
Abingdon Health PLC has launched a seaweed-based alternative for lateral flow test housings, aiming to reduce plastic waste in the production of these diagnostic tools. By partnering with Symbio Technologies Ltd for the supply of compostable bio-based material, the company offers a sustainable solution that maintains the functionality of traditional plastic housings while utilizing standard injection molding techniques. This initiative positions Abingdon Health at the forefront of environmentally friendly innovations in the med-tech industry, potentially impacting stakeholders by aligning with global sustainability trends.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider, offering international customers expertise in lateral flow product development, regulatory support, technology transfer, and manufacturing services. The company specializes in developing rapid diagnostic tests and has capabilities in infectious disease, clinical testing, animal health, and environmental testing. Founded in 2008, Abingdon Health is headquartered in York, England, with laboratories in Doncaster, England, and Madison, Wisconsin, USA.
Average Trading Volume: 164,577
Technical Sentiment Signal: Sell
Current Market Cap: £15.69M
For an in-depth examination of ABDX stock, go to TipRanks’ Overview page.